Back
ProPhase Labs Quote, Financials, Valuation and Earnings
Sponsored
PRPH
Sponsored
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
16
PRPH
ProPhase Labs
Last Price:
0.79
Seasonality Move:
14.29%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.ProPhase Labs Price Quote
$0.79
+0.00 (+5.33%)
(Updated: November 19, 2024 at 5:22 AM ET)
ProPhase Labs Key Stats
Sell
16
ProPhase Labs (PRPH)
is a Sell
Day range:
$0.73 - $0.79
52-week range:
$0.66 - $7.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.14
P/B ratio:
0.49%
Volume:
303.6K
Avg. volume:
187.8K
1-year change:
-82.19%
Market cap:
$18.8M
Revenue:
$44.4M
EPS:
$-1.54
How Much Does ProPhase Labs Make?
-
How Much Are ProPhase Labs's Sales Annually?
PRPH Revenues are $44.4M -
How Much Profit Does ProPhase Labs's Make A Year?
PRPH net income is -$16.8M
Is ProPhase Labs Growing As A Company?
-
What Is ProPhase Labs's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.62% -
What Is ProPhase Labs's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
ProPhase Labs Stock Price Performance
-
Did ProPhase Labs Stock Go Up Last Month?
ProPhase Labs share price went down by -67.19% last month -
Did PRPH's Share Price Rise Over The Last Year?
PRPH share price fell by -82.19% over the past 1 year
What Is ProPhase Labs 52-Week High & Low?
-
What Is ProPhase Labs’s 52-Week High Share Price?
ProPhase Labs has traded as high as $7.48 over the past 52 weeks -
What Is ProPhase Labs’s 52-Week Low Share Price?
ProPhase Labs has traded as low as $0.66 over the past 52 weeks
ProPhase Labs Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy ProPhase Labs?
-
How Much Debt Does ProPhase Labs Have?
Total long term debt quarterly is $17.2M -
How Much Cash Does ProPhase Labs Have?
Cash and short term investments quarterly total is $503K -
What Is ProPhase Labs’s Book Value Per Share?
Book value per share is 2.00
Is ProPhase Labs Cash Flow Positive?
-
What Is PRPH Cash Flow From Operations?
Cash flow from operations (TTM) is -$14.2M -
What Is ProPhase Labs’s Cash Flow From Financing?
Cash flow from financing (TTM) is $13.4M -
What Is ProPhase Labs’s Cash Flow From Investing?
Cash flow from investing (TTM) is $1.2M
ProPhase Labs Return On Invested Capital
-
Is Management Doing A Good Job?
PRPH return on invested capital is -47.22% -
What Is ProPhase Labs Return On Assets?
ROA measures how assets are converting to revenues and is -30.23% -
What Is PRPH Return On Equity?
ROE is a measure of profitability and is -59.59%
ProPhase Labs Earnings Date & Stock Price
-
What Is ProPhase Labs's Stock Price Today?
A single share of PRPH can be purchased today for 0.79 -
What Is ProPhase Labs’s Stock Symbol?
ProPhase Labs trades on the nasdaq under the ticker symbol: PRPH -
When Is ProPhase Labs’s Next Earnings Date?
The next quarterly earnings date for ProPhase Labs is scheduled on March 14, 2025 -
When Is PRPH's next ex-dividend date?
ProPhase Labs's next ex-dividend date is May 24, 2022 -
How To Buy ProPhase Labs Stock?
You can buy ProPhase Labs shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ProPhase Labs Competitors
-
Who Are ProPhase Labs's Competitors?
Below is a list of companies who compete with ProPhase Labs or are related in some way:
ProPhase Labs Dividend Yield
-
What Is PRPH Dividend Yield?
ProPhase Labs’s dividend yield currently is 0% -
What Is ProPhase Labs’s Payout Ratio?
ProPhase Labs’s payout ratio is 0% -
When Did ProPhase Labs Last Pay A Dividend?
The latest dividend pay date is November 19, 2024 -
What Is ProPhase Labs’s Dividend Per Share?
ProPhase Labs pays a dividend of $0.00 per share
ProPhase Labs Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -12.9% |
Revenue: | -62.39% | 11.56% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 18.50 |
Upside from Last Price: | 2249.5% |